drugset

Drugs / Ringer's Lactate Crystalloid Solutions

Follow last change Mar 2026 re-read 2 minutes ago

Ringer's Lactate Crystalloid Solutions

also known as Ringer lactate solution · RLS

Developed for: disorder of acid-base balance
Investigated by: King Chulalongkorn Memorial Hospital

Trials 1 · a red edge is where a trial was stopped

today NCT06030609 · Ph 3

20252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT06030609	Sep 2024 → Feb 2026	disorder of acid-base balance	King Chulalongkorn Memorial Hospital	Completed	No outcome recorded

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT05391607 Comparator	May 2022 → Mar 2023	—	Insel Gruppe AG, University Hospital Bern	Completed	No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Ringer's Lactate Crystalloid Solutions	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05391607 ↗ 1 NCT06030609 ↗
Known as	Ringer lactate solution	“Ringer lactate solution (RLS) and normal saline solution (NSS) with dextrose water (D5W)” NCT06030609 ↗
Known as	RLS	“Ringer lactate solution (RLS) and normal saline solution (NSS) with dextrose water (D5W)” NCT06030609 ↗
Route	Intravenous	“Intravenous administration of Ringer-lactate ratio 3:1 of total of blood loss during removal of the bladder (i.e. the bleeding part) of cystectomy procedures.” NCT05391607 ↗